Clicky

BioPorto(BIOPOR)

Description: BioPorto A/S, an in-vitro diagnostics company, provides diagnostic tests and antibodies to clinicians and researchers worldwide. The company offers the neutrophil gelatinase-associated lipocalin test, a particle-enhanced turbidimetric test that measures NGAL that is used to supplement clinical evaluation and standard tests; monoclonal antibodies for scientific, pharmaceutical, and clinical research use; enzyme-linked immunosorbent assay kits; IVD automated assays; and generic rapid assay device platform for the development of lateral flow assays. It sells its products through own sales team, distributors, and OEM partnerships. The company was founded in 2000 and is headquartered in Hellerup, Denmark.


Keywords: Medicine Natural Sciences Biotechnology Antibodies Monoclonal Antibody Diagnostic Tests Assay Elisa Immunologic Tests Ortho Clinical Diagnostics Lateral Flow Test Suparnostic

Home Page: bioporto.com

Tuborg Havnevej 15
Hellerup, 2900
Denmark
Phone: 45 45 29 00 00


Officers

Name Title
Mr. Anthony P. Pare Chief Exec. Officer
Mr. Neil A. Goldman CPA Exec. VP & CFO
Lars Otto Uttenthal Chief Scientific Officer
Ms. Gry Husby Larsen Gen. Counsel
Ms. Jennifer Zonderman VP of Global Marketing & US Commercialization
Dr. Christopher Bird Chief Medical Officer
Mr. Nis Kruse Exec. VP of Strategic Partnerships and GM of EMEA & APAC

Exchange: CO

Country: DK

Currency: Danish krone (kr)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 9.2232
Price-to-Sales TTM: 31.0062
IPO Date:
Fiscal Year End: December
Full Time Employees: 31
Back to stocks